August 23, 2014
BUFFALO, N.Y. (AP) - Drug-maker ISTA (IS'-tah) Pharmaceuticals has pleaded guilty in New York in a federal case involving its eye drug Xibrom (ZY'-brum) and has agreed to pay more than $30 million.
The Department of Justice says the case was settled in U.S. District Court in Buffalo on Friday.
Irvine, Calif.-based ISTA was acquired by Rochester, N.Y.-based Bausch & Lomb Inc. last year. It admits promoting Xibrom for uses beyond what the Food and Drug Administration approved.
It also pleaded guilty to violating anti-kickback statutes by sponsoring various events hoping to persuade doctors to prescribe Xibrom, an anti-inflammatory approved by the FDA to treat pain and inflammation after cataract surgery. It has agreed to pay $33.5 million in fines and fees.
Bausch & Lomb says the conduct took place from 2006 to 2011 and it's cooperated in the investigation.
Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.